New drug CIN-103 tested for IBS-D, but trial halted early
Symptom relief
Terminated
This Phase 2 trial tested whether CIN-103, taken twice daily, could ease symptoms of irritable bowel syndrome with diarrhea (IBS-D) in adults. The study planned to enroll 421 participants and compare two doses of CIN-103 against a placebo over 12 weeks. However, the trial was ter…
Phase: PHASE2 • Sponsor: CinPhloro Pharma, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC